Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Inmune Bio, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-19Mar-31-19Dec-31-18Sep-30-18Jun-30-18Mar-31-18Dec-31-17Sep-30-17
   10-Q10-Q10-KS-1/A10-Q10-Q10-KS-1/A
Revenues  0.00.00.00.00.00.00.00.0
Cost of goods sold  -2.00.00.00.00.00.01.10.0
Gross profit  2.00.00.00.00.00.0-1.10.0
Selling, general and administrative   [+]1.71.81.41.35.92.70.20.2
Research and development  0.30.10.50.20.30.10.30.0
Other operating expenses  0.4     -1.3 
EBIT   [+]-0.4-1.9-1.9-1.5-6.2-2.8-0.3-0.3
Non-recurring items        0.2 
Interest income  0.0       
Other income (expense), net   [+] 0.0    0.0 
Pre-tax income  -0.4-1.9-1.9-1.5-6.2-2.8-0.4-0.3
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -0.4-1.9-1.9-1.5-6.2-2.8-0.4-0.3
   
Basic EPS   [+]($0.04)($0.20)($0.22)($0.18)($0.71)($0.33)($0.07)($0.05)
Diluted EPS   [+]($0.04)($0.20)($0.22)($0.18)($0.71)($0.33)($0.07)($0.05)
   
Shares outstanding (basic)   [+]10.29.48.78.78.78.56.65.8
Shares outstanding (diluted)   [+]10.29.48.78.78.78.56.65.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy